Home » Syndicated Content »
Taiho Pharma files for approval of cancer drug TAS-102 in JapanJapanese drugmaker
Taiho Pharmaceutical, a subsidiary of Otsuka (TYO: 4768) says that it submitted an application for approval of the manufacture and marketing ...
[Published BioPortfolio - Feb 27 2013]